These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 17041843)

  • 1. Are second-line drugs necessary to control multidrug-resistant tuberculosis?
    Nardell EA; Mitnick CD
    J Infect Dis; 2006 Nov; 194(9):1194-6. PubMed ID: 17041843
    [No Abstract]   [Full Text] [Related]  

  • 2. [Current treatment of tuberculosis].
    García Ramos R; Lado Lado FL; Túnez Bastida V; Pérez del Molino Bernal ML; Cabarcos Ortiz de Barrón A
    An Med Interna; 2003 Feb; 20(2):91-100. PubMed ID: 12703164
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk of acquired drug resistance during short-course directly observed treatment of tuberculosis in an area with high levels of drug resistance.
    Cox HS; Niemann S; Ismailov G; Doshetov D; Orozco JD; Blok L; Rüsch-Gerdes S; Kebede Y
    Clin Infect Dis; 2007 Jun; 44(11):1421-7. PubMed ID: 17479936
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multidrug resistant tuberculosis: a growing public health threat.
    Salahuddin N
    J Coll Physicians Surg Pak; 2009 Sep; 19(9):537-8. PubMed ID: 19728935
    [No Abstract]   [Full Text] [Related]  

  • 5. Antimicrobial resistance in tuberculosis: an international perspective.
    van Helden PD; Donald PR; Victor TC; Schaaf HS; Hoal EG; Walzl G; Warren RM
    Expert Rev Anti Infect Ther; 2006 Oct; 4(5):759-66. PubMed ID: 17140353
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Southern Africa is moving swiftly to combat the threat of XDR-TB.
    Wise J
    Bull World Health Organ; 2006 Dec; 84(12):924-5. PubMed ID: 17242824
    [No Abstract]   [Full Text] [Related]  

  • 7. Children and multidrug-resistant tuberculosis in Mumbai (Bombay), India.
    Karande S; Bavdekar SB
    Emerg Infect Dis; 2002 Nov; 8(11):1360-1. PubMed ID: 12453371
    [No Abstract]   [Full Text] [Related]  

  • 8. Trench warfare in a battle with TB.
    Marshall E
    Science; 2008 Jul; 321(5887):362-4. PubMed ID: 18635790
    [No Abstract]   [Full Text] [Related]  

  • 9. Is this the time to revise the Revised National Tuberculosis Control Programme in India?--yes and no..
    Jindal SK; Agarwal R
    Natl Med J India; 2008; 21(4):159-62. PubMed ID: 19267034
    [No Abstract]   [Full Text] [Related]  

  • 10. Treatment of tuberculosis in children.
    Cruz AT; Starke JR
    Expert Rev Anti Infect Ther; 2008 Dec; 6(6):939-57. PubMed ID: 19053906
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A family cluster of tuberculosis cases, including a case of acquired multidrug resistant tuberculosis.
    Holden J; Trachtman L
    J La State Med Soc; 2012; 164(1):43-7. PubMed ID: 22533114
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Drug-resistant tuberculosis. In South Africa, XDR TB and HIV prove a deadly combination.
    Koenig R
    Science; 2008 Feb; 319(5865):894-7. PubMed ID: 18276863
    [No Abstract]   [Full Text] [Related]  

  • 13. DOTS and DOTS-plus in Hong Kong.
    Yew WW; Tam CM
    Int J Tuberc Lung Dis; 2003 Jan; 7(1):99-100. PubMed ID: 12701843
    [No Abstract]   [Full Text] [Related]  

  • 14. Antituberculosis drug resistance in the south of Vietnam: prevalence and trends.
    Huong NT; Lan NT; Cobelens FG; Duong BD; Co NV; Bosman MC; Kim SJ; van Soolingen D; Borgdorff MW
    J Infect Dis; 2006 Nov; 194(9):1226-32. PubMed ID: 17041848
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Revised National Tuberculosis Control Programme in India: time for revision of treatment regimens and rapid upscaling of DOTS-plus initiative.
    Bhargava A; Jain Y
    Natl Med J India; 2008; 21(4):187-91. PubMed ID: 19267041
    [No Abstract]   [Full Text] [Related]  

  • 16. Drugs for tuberculosis.
    Treat Guidel Med Lett; 2007 Mar; 5(55):15-22. PubMed ID: 17325626
    [No Abstract]   [Full Text] [Related]  

  • 17. Cutaneous extensively drug-resistant tuberculosis.
    Olson DP; Day CL; Magula NP; Sahid F; Moosa MY
    Am J Trop Med Hyg; 2007 Sep; 77(3):551-4. PubMed ID: 17827377
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An expanded DOTS framework for effective tuberculosis control.
    Int J Tuberc Lung Dis; 2002 May; 6(5):378-88. PubMed ID: 12019913
    [No Abstract]   [Full Text] [Related]  

  • 19. Extreme condition, extreme measures? Compliance, drug resistance, and the control of tuberculosis.
    Harper I
    Anthropol Med; 2010 Aug; 17(2):201-14. PubMed ID: 20721757
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Study on the efficacy and safety of short-term treatment including fluoroquinolones anti-tuberculosis drugs for rifampicin resistant pulmonary tuberculosis].
    Kang WL; Xie YG; Tan WG; Chu NH; Li L; You YH; Yang YZ; Wang XM; Yan XL; Miao ZP; Duanmu HJ
    Zhonghua Liu Xing Bing Xue Za Zhi; 2009 Feb; 30(2):179-83. PubMed ID: 19565883
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.